Le Lézard
Classified in: Health
Subjects: SVY, CFG, ESG

Assessment report provides key findings to support inclusion of Autistic people


OTTAWA, ON, May 10, 2022 /CNW/ - Today, the Canadian Academy of Health Sciences (CAHS) is releasing its assessment report on autism. The report was requested by the Public Health Agency of Canada (PHAC) and is to inform the federal government as it considers the development of a National Autism Strategy.

Better inclusion of Autistic people in Canadian society will have a positive impact. The report's key findings focus on the needs of Autistic people and their families, and the tools needed to support their inclusion in society.

The report entitled Autism in Canada: Considerations for future public policy development - weaving together evidence and lived experience is the product of nineteen months of work. Throughout this period, experts and lived experience members of the oversight panel and its working groups assessed evidence as well as best practices and policies, and engaged in a wide-ranging consultation of stakeholders on issues focused on three main topics:

The report provides key findings meant to help guide policy makers at all levels of government as they consider the development of effective programs and flexible strategies adapted to a broad range of needs.  It also supplies Autistic people, their families, service providers, NGOs, government organizations, and all Canadians with much-needed information and pathways for future research.  Its holistic approach is designed to have positive impacts on the lives of Autistic people and their families. The comprehensive report focuses on the individual's entire life, in an informed, balanced, and constructive manner.

The significant and in-depth consultation process highlighted the fundamental consensus between the stakeholders' lived experience perspectives and the scientific evidence, which emerged more often than dissent. This two-pronged approach emphasized the benefits of a sustained and equitable co-creation and collaboration amongst all stakeholders.

Quotes:

"I want to thank the CAHS for their 19 months of work on this report. We will be considering the CAHS' key findings, as well as feedback received from all other partners, including Indigenous Peoples, to create a strategy that support the diverse needs of Autistic Canadians, their families, and caregivers."  

- The Honourable Jean-Yves Duclos, P.C., M.P. Minister of Health

"It was a privilege to be part of this outstanding assessment that has the capacity to have such a tremendous significance for the lives of Autistic people and their families."

- Lonnie Zwaigenbaum, Chair, Autism Assessment Oversight Panel

"We listened to the voices of Autistic people throughout the process. This resulted in a balanced and comprehensive approach that can be found in this report."

- Aaron Bouma, Vice Chair, Autism Assessment Oversight Panel

"Autistic people have so much to offer to society. This report provides key findings that will support the economic and social inclusion of Autistic people in Canada."

 - Mélanie Couture, Vice Chair, Autism Assessment Oversight Panel

Associated Links :

CAHS Autism Information Centre
Centre d'information sur l'autisme de l'ACSS
Link to full report
Link to summary report
Link to Engagement Report
Link to Easy Read document
Link to Aaron Bouma Video
Link to Mélanie Couture Video
Link to Lonnie Zwaigenbaum Video

About CAHS

Nearly 850 CAHS Fellows are drawn from all disciplines from Canada's academia, health care and research institutes.

In the past, CAHS has completed assessments on key issues such as:

For a full list of our previously completed assessments, please click here.

SOURCE Canadian Academy of Health Sciences


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: